Bruce V. Bigelow
The British multinational pharmaceutical giant GlaxoSmithKline (NYSE: GSK) is establishing an R&D outpost in San Diego to help manage its relationships with venture capital firms, and …
Bruce V. Bigelow
The British multinational pharmaceutical giant GlaxoSmithKline (NYSE: GSK) is establishing an R&D outpost in San Diego to help manage its relationships with venture capital firms, and …